Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF PILL
17.99 USD +0.67 (+3.87%)
At closeNov 11, 2026, 5:43 PM EST
17.90 -0.09 -0.50%
After hours · Nov 11, 5:43 PM ET
17.27 Day range 17.99
8.79 52-week range 24.15
- YTD
- +46.26%
- 1 year
- +90.57%
News
etftrends.com Top Performing Leveraged/Inverse ETFs: 06/14/2026 Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
benzinga.com Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks' Trump's "Great Healthcare Plan" targets PBM kickbacks to cut costs. Experts confirm these fees act as an industry "vig" driving up prices.
etftrends.com Top Performing Leveraged/Inverse ETFs: 12/14/2025 Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
etftrends.com Top Performing Leveraged/Inverse ETFs: 11/16/2025 Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
benzinga.com Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' Eli Lilly CEO Dave Ricks slams PBM "rent taking" for driving $275 insulin price bubble and explains why he's ready to "disintermediate them."
benzinga.com Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms President Donald Trump's proposed 100% tariffs on foreign pharmaceuticals will ultimately be paid by American patients and insurers, not foreign drug companies, according to economist Justin Wolfers.
etftrends.com As M&A Deals Rise, Can Biotech Pharma Break Loose? After a relatively sluggish 2024 for mergers & acquisitions (M&A) activity in the biopharma sector, the environment could be more conducive for deals in the rest of 2025. The industry, like the rest…
benzinga.com Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing Mark Cuban explains how PBMs & wholesalers force pharmacies into exclusive deals, creating a 'stranglehold' on prescription drug prices.
etftrends.com Top Performing Leveraged/Inverse ETFs: 08/17/2025 Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
etftrends.com CURE: Make an Adventurous Bet on an Undervalued Sector The healthcare sector, the fifth-largest sector exposure in the S&P 500, was once a reliable destination for investors who wanted dependable performance without taking on significant risk. The group…
benzinga.com Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More' Mark Cuban challenges the idea that high drug prices are necessary for R&D, PBMs take away from profits, leaving less for innovation.
benzinga.com Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' Barclays has said that it's hard to predict which firm would be affected the most by pharma tariffs, except for Novo Nordisk.
benzinga.com Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to "benefit" except for the rest.
benzinga.com Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices.
benzinga.com Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion Trump signed an executive order to lower drug prices, which could hit pharmacy benefit managers (PBMs) hard. PBMs have come under scrutiny for opaque pricing practices. Mark Cuban calls PBMs a racket.
benzinga.com Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies Even as Donald Trump paused the reciprocal tariffs for 90 days, he later confirmed that pharmaceutical companies would face tariffs.
etftrends.com Top Performing Leveraged/Inverse ETFs: 07/28/2024 These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
etftrends.com Top Performing Leveraged/Inverse ETFs: 07/14/2024 These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
newsfilecorp.com CSE Bulletin: Delist - Canntab Therapeutics Limited (PILL) Toronto, Ontario--(Newsfile Corp. - le 14 juin/June 2024) - The common shares of Canntab Therapeutics Limited will be delisted from the CSE at market close today, June 14, 2024. Canntab Therapeutics…
etftrends.com Finding Opportunity in Unloved Healthcare ETFs Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?
etftrends.com Top Performing Leveraged/Inverse ETFs: 02/18/2024 These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
zacks.com 5 Best Leveraged ETFs of First Half of Q1 We highlight a bunch of the best-performing leveraged equity ETFs from different corners of the market that are leaders in their segments in the first half of Q1.
zacks.com 5 Best Inverse/Leveraged ETFs of Last Week The optimism surrounding the likely Fed rate cuts in 2024 aided the rally in the market last week, barring some occasional dips.
seekingalpha.com Can Health Care Stocks Outperform Again In 2023? How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
etftrends.com Top Performing Leveraged/Inverse ETFs: 09/11/2022 Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
etftrends.com Top Performing Leveraged/Inverse ETFs: 06/26/2022 Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
seekingalpha.com Pharma In Transition: Context And Opportunities The pending separation of consumer care businesses by pharmaceutical companies is understandable and may offer investment opportunities.
zacks.com Best Leveraged ETF Areas of Last Week Wall Street was at the record high last week due to upbeat corporate earnings, strong jobs data and Pfizer's pill study.
etftrends.com 3 ETFs to Access a Changing Pharmaceutical Industry A changing pharmaceutical industry is setting up a few trades in the leveraged fund space, specifically for ETFs from Direxion Investments. One of the catalysts for change, especially within the past…
zacks.com 5 Best Leveraged ETFs of Last Week Wall Street was overall upbeat last week. Though concerns about the spread of the Delta Variant of coronavirus worried investors, low rates boosted the demand for stock investments.
benzinga.com 3 Pharmaceutical ETFs That Could Be Due For A Rebound These three pharmaceutical ETFs have dropped to support, which means they may be about to rebound. Support is a large concentration of buyers who have gathered around the same price level. At support…
benzinga.com ~150 Prescription Drugs, Including Antibiotics, Generics, Some Branded Drugs without Alternatives Face Shortages Due to Coronavirus 
benzinga.com Expert: 'I've had far fewer defensive conversations than I would have expected' About The Market 
benzinga.com With Earnings On Tap, A Stir In This Leveraged Pharmaceuticals ETF - benzinga.com It Could Be Time For This Pharma ETF
- benzinga.com Pharma Catches Another Case Of M&A Fever
benzinga.com Having Fun With Pharma ETFs 
benzinga.com A Lazarus Act For This Pharma ETF 
benzinga.com CUREs For The Ordinary December Trade